Interim data from Phase I dose-escalation study of mRNA cancer Immunotherapy (mRNA-4359) has shown promise in patients with advanced solid tumors. The investigational mRNA cancer immunotherapy...
Interim data from Phase I dose-escalation study of mRNA cancer Immunotherapy (mRNA-4359) has shown promise in patients with advanced solid tumors. The investigational mRNA cancer immunotherapy...
Credit: Dr_Microbe/Getty Images A new study demonstrates an immunotherapy-based approach to treating pancreatic cancer in mice that combines the delivery of STING and TLR4 innate immune...
Researchers at the University of Sheffield have discovered a new immunotherapy that uses nanoparticles to activate immune cells to kill cancer cells and delay resistance to...
This approach offers hope for a revolution in the treatment of colorectal cancer. A groundbreaking immunotherapy drug has shown promising results in the treatment of colorectal...
Vaccinia virus is a therapeutic tool with different biomedical applications depending on its susceptibility characteristics. For example, MVA (Modified Vaccinia Ankara) is unable to replicate in...
Recent Comments